BackFidelity Select Health Care Portfolio Overview

Fidelity Select Health Care Portfolio Net Income

Fidelity Select Health Care Portfolio's net income is $-1.4M, below the sector sector average of $96M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$2.40M
141.2% YoY

As of Sep 2023

Annual Net Income (TTM)

-$1.37M
93.88% YoY

Trailing 12 months ending Sep 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Fidelity Select Health Care Portfolio (FSPHX) FAQ

The latest net income for FSPHX is $-1.4M as of September 2023. That compares with $-22M in the prior-year period — up 93.9% year over year. That is below the sector sector average of $96M. Investors often review this figure alongside Fidelity Select Health Care Portfolio's historical trend and sector peers before judging valuation or financial health.

Over the past year, FSPHX's net income moved from $-22M to $-1.4M — a 93.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fidelity Select Health Care Portfolio's operating scale or balance-sheet position.

Against its sector companies, FSPHX currently prints $-1.4M for net income, while the sector average sits near $96M. That is roughly 101.4% below the sector mean. Large gaps often invite a closer look at Fidelity Select Health Care Portfolio's growth, margins, and balance sheet.

A net income figure of $-1.4M for FSPHX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $96M. Explore the charts below for those layers of context.

After noting FSPHX's net income ($-1.4M), review year-over-year change from $-22M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.